We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Your guide to a disrupted world
Add this topic to your myFT Digest for news straight to your inbox
Scotland hit hardest in the UK as cases climb 40% to leave one in 20 people suffering from the disease
Governments need to plan now for what could be a tough autumn
WHO debates raising classification of outbreak as some authorities widen eligibility for vaccines
Pharma companies are hoping to catch up with rivals as they report promising trial results for jab
Mathematical modelling looked at deaths directly and indirectly linked to jabs
Javid says he asked officials to revise previous plans that would exclude under-65s
Xi Jinping orders public health policy to prioritise Covid control over all other diseases
UK health agency investigating possibility of community transmission says risk to public ‘extremely low’
US biotech group says shot targeting both first strain and Omicron could help avert ‘large rise’ in cases
Government seeks to secure domestic jab supply and prepare for future pandemics in deal with Boston biotech
After years in retreat, the disease is once again on the rise across the continent
US pharma group to pay €90.5mn for 8% in deal that will boost joint Lyme disease programme
Financiers suffering lacklustre first half performance are poised to cancel summer plans in bid to claw back business
Facilities used to house foreign athletes during February Games converted into isolation centres
Omicron offshoots BA.4 and BA.5 drive increase in infections in Portugal, UK, France and Germany
Recommendation by health agency advisory group marks shift in thinking of global health authorities
Cancer Research UK will eventually spend £295mn with National Cancer Institute on projects to understand and prevent tumour growth
US prepares to roll out jabs to last age group without access once regulatory approval is received
Genetic and archaeological evidence show plague pandemic began in Kyrgyzstan in 1338
The German company is ploughing Covid vaccine profits into oncology but its technology is still largely unproven
Morgan Stanley chief says he is ‘totally relaxed’, pointing to strength of consumer credit
Beijing’s techno-authoritarian approach to containing the virus is just another iteration of digital dystopia
Successful trials for RSV vaccine add much-needed lift to the UK drugmaker’s pipeline
Drive to identify emerging viruses that pass from animals to humans comes amid fears over spread of monkeypox
Revolving lockdowns are likely to exact a heavy economic toll in 2022
International Edition
